• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在澳大利亚,我们是如何管理慢性阻塞性肺疾病的?

How have we been managing chronic obstructive pulmonary disease in Australia?

作者信息

Matheson M C, Abeysena C, Raven J M, Skoric B, Johns D P, Abramson M J, Walters E H

机构信息

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

出版信息

Intern Med J. 2006 Feb;36(2):92-9. doi: 10.1111/j.1445-5994.2006.01011.x.

DOI:10.1111/j.1445-5994.2006.01011.x
PMID:16472263
Abstract

AIM

Although chronic obstructive pulmonary disease (COPD) is a main cause of disability, hospital admissions and premature deaths in Australia, little is known about the community management of COPD in relation to recently published guidelines. The aim of the article was to report on COPD management in a community based cohort.

METHODS

A random sample of adults aged between 45 and 70 years drawn from the electoral roll participated in the study. They completed a detailed respiratory questionnaire, spirometry, methacholine challenge and measurement of transfer factor. COPD was defined according to the Global initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Current asthma was defined as wheeze during the last 12 months together with bronchial hyperreactivity. Subjects were classified as either COPD-only, asthma-only or both asthma and COPD.

RESULTS

Of 1224 subjects completing spirometry, 39 (3.5%) met the GOLD criteria for stage 2 or 3 COPD, asthma-only was found in 99 (8.9%) subjects and 40 (3.6%) subjects had both asthma and COPD. The COPD-only group was significantly older than the other two groups. More than 40% of subjects with COPD did not have a diagnosis of COPD from their doctors. Only 48.7% of subjects with COPD had ever been prescribed medication for their breathing. More than two-thirds of all subjects had seen a doctor for breathing problems, but very few had seen a general practitioner in the last 12 months and even fewer had respiratory function tests.

CONCLUSIONS

Most subjects with COPD are being undertreated. Diagnosis, monitoring and referral systems should be improved. Preventive activities such as influenza vaccination and smoking cessation should be intensified.

摘要

目的

尽管慢性阻塞性肺疾病(COPD)是澳大利亚残疾、住院和过早死亡的主要原因,但对于COPD的社区管理与最近发布的指南之间的关系知之甚少。本文的目的是报告一个基于社区的队列中的COPD管理情况。

方法

从选民名册中随机抽取45至70岁的成年人参与研究。他们完成了一份详细的呼吸问卷、肺活量测定、乙酰甲胆碱激发试验和转移因子测量。COPD根据慢性阻塞性肺疾病全球倡议(GOLD)标准定义。当前哮喘定义为过去12个月内喘息并伴有支气管高反应性。受试者被分类为仅患有COPD、仅患有哮喘或同时患有哮喘和COPD。

结果

在1224名完成肺活量测定的受试者中,39名(3.5%)符合GOLD标准的2期或3期COPD,99名(8.9%)受试者仅患有哮喘,40名(3.6%)受试者同时患有哮喘和COPD。仅患有COPD的组比其他两组年龄显著更大。超过40%的COPD患者未被医生诊断出患有COPD。仅48.7%的COPD患者曾因呼吸问题被开过药。超过三分之二的所有受试者因呼吸问题看过医生,但在过去12个月内很少有人看过全科医生,进行呼吸功能测试的人更少。

结论

大多数COPD患者治疗不足。应改进诊断、监测和转诊系统。应加强流感疫苗接种和戒烟等预防措施。

相似文献

1
How have we been managing chronic obstructive pulmonary disease in Australia?在澳大利亚,我们是如何管理慢性阻塞性肺疾病的?
Intern Med J. 2006 Feb;36(2):92-9. doi: 10.1111/j.1445-5994.2006.01011.x.
2
External validity of randomized controlled trials in COPD.慢性阻塞性肺疾病随机对照试验的外部效度
Respir Med. 2007 Jun;101(6):1313-20. doi: 10.1016/j.rmed.2006.10.011. Epub 2006 Nov 17.
3
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.40岁及以上初级保健患者中慢性阻塞性肺疾病(COPD)和哮喘的误诊情况。
J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
4
The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.韩国根据支气管扩张剂后GOLD标准诊断的慢性阻塞性肺疾病(COPD)的当地患病率。
Int J Tuberc Lung Dis. 2006 Dec;10(12):1393-8.
5
Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.根据英国胸科学会(BTS)、欧洲呼吸学会(ERS)、慢性阻塞性肺疾病全球倡议(GOLD)和美国胸科学会(ATS)标准,慢性阻塞性肺疾病的患病率与医生诊断、症状、年龄、性别及吸烟习惯的关系
Respiration. 2005 Sep-Oct;72(5):471-9. doi: 10.1159/000087670.
6
Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.中国慢性阻塞性肺疾病的患病率:一项基于人群的大型调查。
Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. doi: 10.1164/rccm.200612-1749OC. Epub 2007 Jun 15.
7
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告
Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.
8
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.在住院急性哮喘或慢性阻塞性肺疾病患者中比较左旋沙丁胺醇和消旋沙丁胺醇:一项为期2周的多中心随机开放标签研究。
Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010.
9
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.慢性阻塞性肺疾病中辅助吸入性糖皮质激素的益处与风险:一项荟萃分析
Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.
10
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].[德国慢性阻塞性肺疾病(COPD)的患病率。BOLD研究结果]
Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3.

引用本文的文献

1
Clinical characteristics of adults with self-reported diagnosed asthma and/or COPD: data from the BOLD Australia Study.自我报告诊断为哮喘和/或慢性阻塞性肺疾病的成年人的临床特征:来自澳大利亚BOLD研究的数据。
ERJ Open Res. 2023 Aug 21;9(4). doi: 10.1183/23120541.00098-2023. eCollection 2023 Jul.
2
Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial.澳大利亚初级保健中慢性阻塞性肺疾病(COPD)早期检测与管理的跨学科护理模式(RADICALS):一项整群随机对照试验的研究方案
BMJ Open. 2017 Sep 18;7(9):e016985. doi: 10.1136/bmjopen-2017-016985.
3
The use of COPD maintenance therapy following spirometry in General Practice.
全科医疗中肺量计检查后慢性阻塞性肺疾病维持治疗的应用
Eur Clin Respir J. 2016 Jun 22;3. doi: 10.3402/ecrj.v3.30232. eCollection 2016.
4
Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD.慢性阻塞性肺疾病治疗中临床实践指南推荐药物治疗的障碍调查
Pharm Pract (Granada). 2007;5(2):74-7. doi: 10.4321/s1886-36552007000200004.
5
A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol.由执业护士-全科医生团队对慢性阻塞性肺疾病进行早期干预的实用集群随机对照试验:研究方案。
Implement Sci. 2012 Sep 7;7:83. doi: 10.1186/1748-5908-7-83.
6
Signs of progress in the Australian post-2000 COPD experience, but some old problems remain.澳大利亚 2000 年后 COPD 发病情况有所改善,但仍存在一些老问题。
Int J Chron Obstruct Pulmon Dis. 2012;7:357-66. doi: 10.2147/COPD.S30003. Epub 2012 Jun 7.
7
Forecasts of COPD mortality in Australia: 2006-2025.澳大利亚 COPD 死亡率预测:2006-2025 年。
BMC Med Res Methodol. 2012 Feb 21;12:17. doi: 10.1186/1471-2288-12-17.
8
Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study.澳大利亚全科医疗中哮喘与慢性阻塞性肺疾病诊断的准确性:一项混合方法研究。
Prim Care Respir J. 2012 Jun;21(2):167-73. doi: 10.4104/pcrj.2011.00103.
9
Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study.西澳大利亚州慢性呼吸系统疾病老年人的死亡率:一项队列研究。
BMC Public Health. 2010 Jul 1;10:385. doi: 10.1186/1471-2458-10-385.
10
Policy challenges from the "White" Senate inquiry into workplace-related health impacts of toxic dusts and nanoparticles.“白人”参议院对有毒粉尘和纳米颗粒对工作场所相关健康影响的调查所带来的政策挑战。
Aust New Zealand Health Policy. 2006 Jun 17;3:7. doi: 10.1186/1743-8462-3-7.